𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): a phase II multicenter trial

✍ Scribed by Mancarella, S.; Lorusso, V.; Manzione, L.; Antimi, M.; De Vita, F.; Santoro, A.; Maiorino, L.; Mattioli, R.; Luporini, G.; Bilancia, D.; De Lena, M.

Book ID
123530392
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
279 KB
Volume
35
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gemcitabine and carboplatin in advanced
Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract : An alternative therapy
✍ Miquel NoguΓ©-Aliguer; Joan Carles; Antonio Arrivi; Oscar Juan; Lorenzo Alonso; A πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

## Abstract ## BACKGROUND Cisplatin‐based combinations are considered to be the standard treatment for advanced transitional cell carcinoma (TCC) of the urothelium. Many of the patients are elderly with concomitant diseases or impaired renal function. We studied the tolerance and activity of the g

A phase II study of mitoguazone and vinb
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract
✍ John T. Barrett; Bruno Orofiamma; Janardan D. Khandekar; Paul P. Carbone; Robert πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 330 KB πŸ‘ 2 views

This is a comparative study to evaluate response rate to mitoguazone (MGBG) and vinblastine (VLB) in 52 evaluable patients with advanced transitional cell carcinoma of the urinary tract. Of 38 patients with measurable disease, two of 18 (11%) on MGBG had partial remission (95% confidence interval: 0